TR200402073T4 - Gaba A reseptör olarak benzodiazepin türevleri - Google Patents

Gaba A reseptör olarak benzodiazepin türevleri

Info

Publication number
TR200402073T4
TR200402073T4 TR2004/02073T TR200402073T TR200402073T4 TR 200402073 T4 TR200402073 T4 TR 200402073T4 TR 2004/02073 T TR2004/02073 T TR 2004/02073T TR 200402073 T TR200402073 T TR 200402073T TR 200402073 T4 TR200402073 T4 TR 200402073T4
Authority
TR
Turkey
Prior art keywords
alkyl
phenyl
halogen
hydrogen
alkoxy
Prior art date
Application number
TR2004/02073T
Other languages
English (en)
Inventor
Masciadri Raffaello
William Thomas Andrew
Wichmann Juergen
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of TR200402073T4 publication Critical patent/TR200402073T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formül (L) bilesikleri ve farmasötik açidan kabul edilebilir asit ekleme tuzlari olup, özelligi, R1'in hidrojen, halojen, C1-7-alkail, C1-7-alkoksi,hidroksi, siyano, triflüorometil, triflüorometoksi, veya C1-7-alkiltiyo olmasi; R2'nin-C(O)O-C1-7-alkil, isoksazol, 1,2,4-oksadiazol-3-yl veya 1,2,4-oksadiazol-5-yl olmasi,halkalar ihtiyar olarak C1-7-alkil,triflüorometil veya C3-7-sikoalkil ikameli olabilir;R3'ün hidrojen, C1-7-alkil,-(CH2)n-C3-7-sikoalkil, -(CH2)n-halojen,-(CH2)n-pyridin-4-yl olmasi, veya fenil halkasi C1-7-alkoksi, halojen,-SO2CH3,fenil, OCF3,fenil, OCF3,nitro, CF3,-NR2 arasindan bir veya iki ikameyle ihtiyari olarak ikameli-(CH2)n-fenil olmasi; veya ihtiyari olarak C1-7-alkil veya C1-7-alkoksi ikameli-(CH2)n-indoli olmasi; yada pirolidinil-5-okzo,-C(O)-NR2,(CH2)n-OH,-(CH2)n-NR2 veya-(CH2)n-benzo[1,3]dioksol olmasidir; R'nin hidrojen, veya C1-7-alkil olmasi; n'nin 0,1,2,3 olmasidir.
TR2004/02073T 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri TR200402073T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
TR200402073T4 true TR200402073T4 (tr) 2004-10-21

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02073T TR200402073T4 (tr) 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri

Country Status (41)

Country Link
US (1) US6743789B2 (tr)
EP (1) EP1337535B1 (tr)
JP (1) JP4088151B2 (tr)
KR (1) KR100504300B1 (tr)
CN (1) CN1191255C (tr)
AR (1) AR031345A1 (tr)
AT (1) ATE268776T1 (tr)
AU (2) AU2002217007B2 (tr)
BG (1) BG107817A (tr)
BR (1) BR0115393A (tr)
CA (1) CA2427576C (tr)
CZ (1) CZ295256B6 (tr)
DE (1) DE60103776T2 (tr)
DK (1) DK1337535T3 (tr)
EC (1) ECSP034607A (tr)
ES (1) ES2220831T3 (tr)
GC (1) GC0000375A (tr)
GT (1) GT200100230A (tr)
HK (1) HK1062442A1 (tr)
HR (1) HRP20030360A2 (tr)
HU (1) HUP0303281A3 (tr)
IL (1) IL155813A0 (tr)
JO (1) JO2359B1 (tr)
MA (1) MA26962A1 (tr)
MX (1) MXPA03004251A (tr)
MY (1) MY141675A (tr)
NO (1) NO324706B1 (tr)
NZ (1) NZ525413A (tr)
PA (1) PA8532401A1 (tr)
PE (1) PE20020583A1 (tr)
PL (1) PL362925A1 (tr)
PT (1) PT1337535E (tr)
RU (1) RU2278865C2 (tr)
SI (1) SI1337535T1 (tr)
SK (1) SK7232003A3 (tr)
TR (1) TR200402073T4 (tr)
TW (1) TWI239333B (tr)
UY (1) UY27026A1 (tr)
WO (1) WO2002040487A2 (tr)
YU (1) YU35603A (tr)
ZA (1) ZA200303435B (tr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
US7626029B2 (en) * 2003-06-19 2009-12-01 Daiichi Pharmaceutical Co., Ltd. Method of selectively introducing amino substituent
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2006020959A2 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
RU2007112675A (ru) * 2004-10-12 2008-11-20 Ф.Хоффманн-Ля Рош Аг (Ch) ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ
WO2006045429A1 (en) * 2004-10-20 2006-05-04 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
JP4783375B2 (ja) 2004-10-20 2011-09-28 エフ．ホフマン−ラ ロシュ アーゲー イミダゾベンゾジゼピン誘導体
JP4783380B2 (ja) 2004-12-14 2011-09-28 エフ．ホフマン−ラ ロシュ アーゲー Ｇａｂａレセプタ調節物質としての四環系イミダゾ−ベンゾジアゼピン類
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
WO2007053596A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
CN102216304B (zh) 2008-11-18 2014-07-09 弗·哈夫曼-拉罗切有限公司 二氢四氮杂苯并薁的烷基环己基醚
JP5452608B2 (ja) * 2008-11-28 2014-03-26 エフ．ホフマン−ラ ロシュ アーゲー バソプレシン介在受容体アンタゴニストとしての使用のためのジヒドロテトラアザベンゾアズレンのアリールシクロヘキシルエーテル
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
US9145372B2 (en) 2010-11-15 2015-09-29 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
JP2015529254A (ja) * 2012-09-21 2015-10-05 ユーダブリューエム・リサーチ・ファウンデーション，インコーポレーテッド 喘息における気道の過敏症及び炎症を制御するための新規なｇａｂａａアゴニスト及び使用方法
CA3123897C (en) 2013-12-20 2024-02-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2990004C (en) * 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
JP2021528427A (ja) * 2018-06-19 2021-10-21 エージンバイオ， インコーポレイテッド 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (tr) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
CA2427576C (en) 2007-11-06
PL362925A1 (en) 2004-11-02
KR20030045192A (ko) 2003-06-09
ATE268776T1 (de) 2004-06-15
MY141675A (en) 2010-06-15
WO2002040487A3 (en) 2002-09-26
US20020103371A1 (en) 2002-08-01
RU2003116895A (ru) 2005-02-20
EP1337535B1 (en) 2004-06-09
TWI239333B (en) 2005-09-11
NO20032208D0 (no) 2003-05-15
UY27026A1 (es) 2002-06-20
BG107817A (bg) 2004-07-30
ECSP034607A (es) 2003-06-25
BR0115393A (pt) 2004-07-06
GT200100230A (es) 2002-07-04
NO20032208L (no) 2003-05-15
GC0000375A (en) 2007-03-31
SI1337535T1 (en) 2004-10-31
ES2220831T3 (es) 2004-12-16
JO2359B1 (en) 2006-12-12
NZ525413A (en) 2005-02-25
YU35603A (sh) 2006-05-25
PA8532401A1 (es) 2002-08-26
AR031345A1 (es) 2003-09-17
MXPA03004251A (es) 2003-09-22
DE60103776D1 (de) 2004-07-15
JP2004517070A (ja) 2004-06-10
AU2002217007B2 (en) 2006-11-30
CN1474820A (zh) 2004-02-11
CA2427576A1 (en) 2002-05-23
DK1337535T3 (da) 2004-10-25
HUP0303281A3 (en) 2005-05-30
CN1191255C (zh) 2005-03-02
PE20020583A1 (es) 2002-07-06
CZ295256B6 (cs) 2005-06-15
CZ20031597A3 (cs) 2003-11-12
SK7232003A3 (en) 2004-03-02
WO2002040487A2 (en) 2002-05-23
KR100504300B1 (ko) 2005-07-28
HUP0303281A2 (hu) 2004-01-28
HRP20030360A2 (en) 2005-04-30
US6743789B2 (en) 2004-06-01
DE60103776T2 (de) 2005-07-14
NO324706B1 (no) 2007-12-03
RU2278865C2 (ru) 2006-06-27
ZA200303435B (en) 2004-08-05
IL155813A0 (en) 2003-12-23
MA26962A1 (fr) 2004-12-20
JP4088151B2 (ja) 2008-05-21
PT1337535E (pt) 2004-09-30
HK1062442A1 (en) 2004-11-05
EP1337535A2 (en) 2003-08-27
AU1700702A (en) 2002-05-27

Similar Documents

Publication Publication Date Title
TR200402073T4 (tr) Gaba A reseptör olarak benzodiazepin türevleri
ATE265415T1 (de) 2-alkyl-5-halogen-pent-4-encarbonsäuren und deren herstellung
MY149463A (en) Novel compounds
RS51545B (en) THIAZOL PIRAZOLOPIRAMIDINS AS ANTAGONISTS OF CRF1 RECEPTORS
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
HU9501622D0 (en) 1,4-benzodiazepine derivatives and their use as cck-mudulators
RS20100169A (en) INTERMEDIATES FOR DIOXAN-2-ALKYLCARBAMATE
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
WO2009044007A3 (fr) Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique
IT1320162B1 (it) Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ATE355843T1 (de) N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- and tricyclische azepine und diazepine als vasopressin-agonisten
EP1619040A3 (en) Thermal transfer recording material and thermal transfer recording method
ZA822792B (en) Amide derivatives
EA200200973A1 (ru) Пиридазинилфенилгидразоны, применяемые при застойной сердечной недостаточности
HUP0001397A2 (hu) 3-Amino-3-aril-propán-1-ol-származékok, előállításuk és felhasználásuk
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
CO5180634A1 (es) Sulfonamidas sustituidas con naftilo
YU30392A (sh) Piridazinon sirćetne kiseline
HUP9701325A1 (hu) Új 2,3-benzodiazepin-származékok
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
TR200000764T2 (tr) Fosfolamban inhibitörleri olarak, 1-okza, aza ve tiyanaftalin-2-on'ların biseterleri.
TH50278A (th) อนุพันธ์ไพริโดไพราโนอะเซพีน การเตรียมสารดังกล่าว และการนำไปใช้ทางการรักษา
IT1290403B1 (it) Analoghi del metabolita attivo della leflunomide